Radiotherapy Clinical Trials
106 recruitingRadiation
Phase 252Not Applicable19Phase 316Phase 113
Showing 1–20 of 106 trials
Recruiting
Not Applicable
Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients
Non-small Cell Lung Cancer (NSCLC)Stage IV
Swiss Cancer Institute128 enrolled7 locationsNCT06114108
Recruiting
Phase 1Phase 2
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeAstrocytoma, Grade III
Debiopharm International SA116 enrolled17 locationsNCT05765812
Recruiting
Phase 1
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
GlioblastomaGliosarcoma
Memorial Sloan Kettering Cancer Center60 enrolled10 locationsNCT06934889
Recruiting
Phase 2Phase 3
Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
West China Hospital60 enrolled2 locationsNCT07353671
Recruiting
Phase 2
Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.
Radiotherapy-induced Oral Mucositis
West China Hospital128 enrolled1 locationNCT07339774
Recruiting
Phase 2
Comparing Moderately Ultra Hypofractionated Radiation Treatments for Prostate Cancer
Post-Operative Prostate Cancer
University Health Network, Toronto204 enrolled2 locationsNCT06409910
Recruiting
Phase 2
Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer
Prostate Metastases
University Health Network, Toronto40 enrolled1 locationNCT05656794
Recruiting
Phase 2Phase 3
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
Prostate Cancer
Cancer Research Antwerp493 enrolled9 locationsNCT06282588
Recruiting
Not Applicable
Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer
Prostate Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain188 enrolled1 locationNCT07245745
Recruiting
Phase 2
IVIM & OLINK in Sarcoma
Soft Tissue Sarcoma
University Health Network, Toronto145 enrolled1 locationNCT05950594
Recruiting
Not Applicable
Shortened High-dose Palliative Radiotherapy for Lung Cancer
Stage IV Lung Cancer
University Hospitals Coventry and Warwickshire NHS Trust37 enrolled4 locationsNCT06483308
Recruiting
Comparing SBRT to CRT in Patients With Spinal Metastases
Spinal Metastases
University Health Network, Toronto100 enrolled1 locationNCT05589701
Recruiting
Curatively Intended Thoracic Reirradiation
Radiotherapy Side EffectLung CancerThoracic Cancer+2 more
University of Aarhus500 enrolled1 locationNCT06950073
Recruiting
Phase 2
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
HCC
Chinese University of Hong Kong40 enrolled2 locationsNCT06823375
Recruiting
Phase 2
A Study of Surgery and Radiotherapy in People With Breast Cancer
Metastatic Breast CancerHER2-positive Breast Cancer
Memorial Sloan Kettering Cancer Center162 enrolled7 locationsNCT07053085
Recruiting
Phase 3
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
Thyroid Cancer
Fudan University124 enrolled1 locationNCT06558981
Recruiting
Phase 1
NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
Locally Advanced Rectal Cancer (LARC)
Akamis Bio30 enrolled6 locationsNCT06459869
Recruiting
Not Applicable
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
Prostate Cancer MetastaticRadiation Therapy
Karin Soderkvist118 enrolled7 locationsNCT04983095
Recruiting
Phase 3
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Esophageal CarcinomaRadiotherapyImmunotherapy
Fudan University452 enrolled1 locationNCT06964568
Recruiting
Phase 3
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Diffuse Intrinsic Pontine GliomaDiffuse Midline Glioma, H3K27-alteredDiffuse Midline Glioma, H3 K27M-Mutant
Gustave Roussy, Cancer Campus, Grand Paris433 enrolled50 locationsNCT05476939